| EPB122 | Non-invasive identification of severe NAFLD and risk stratification of clinical outcomes using Fibroscan-AST (FAST) score in 1683 people with HIV | E-poster | Hepatic complications (e.g., NASH) |
| EPB123 | Incidence and disease severity of non-alcoholic fatty liver disease among people living with HIV in Thailand | E-poster | Hepatic complications (e.g., NASH) |
| PESUB18 | PROGRESSION OF HEPATIC STEATOSIS IN PEOPLE WITH HIV ON INTEGRASE INHIBITORS | Poster exhibition | Hepatic complications (e.g., NASH) |
| EPA077 | Active tuberculosis co-infection is associated with broad HIV-1 antibody responses | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA078 | Role of PD-1, TIGIT and TIM3 on NK cell exhaustion and function in HIV/HCV coinfection, and the impact of HCV elimination in the long term | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA079 | Maternal HIV status and risk of infant M. tuberculosis infection | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA080 | Impact of chronic HCV infection on CD4-T cells permissiveness to HIV infection and viral reservoir persistence | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA081 | HPV circulating tumoural DNA as a potential biomarker to monitor anal lesions in HIV-infected men who have sex with men (MSM) | E-poster | HIV and co-infections (TB, viral hepatitis, SARS-CoV2, other) |
| EPA070 | High adaptive NK cell frequencies reduce the risk of developing coronary atherosclerotic plaque in cytomegalovirus infected people living with HIV | E-poster | HIV and co-morbidities |
| EPA071 | Scaling-up HPV testing for cervical cancer screening in WLHIV in Zambia | E-poster | HIV and co-morbidities |